VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.
Publications found:
61,963
Sort by:
Resistant Hypertension: Drug Development Pipeline Study, H1 2018
US$ 806.00
... . The most comprehensive pipeline review “Resistant Hypertension- Drug Development Pipeline Study” provides in-depth analysis and update information on Resistant Hypertension pipeline drugs. Current status of all the drugs in the Resistant Hypertension pipeline is provided in the ...
March 2018
28 pages
Portal Hypertension: Drug Development Pipeline Study, H1 2018
US$ 806.00
... . The most comprehensive pipeline review “Portal Hypertension- Drug Development Pipeline Study” provides in-depth analysis and update information on Portal Hypertension pipeline drugs. Current status of all the drugs in the Portal Hypertension pipeline is provided in the ...
March 2018
31 pages
Ocular Hypertension: Drug Development Pipeline Study, H1 2018
US$ 806.00
... . The most comprehensive pipeline review “Ocular Hypertension- Drug Development Pipeline Study” provides in-depth analysis and update information on Ocular Hypertension pipeline drugs. Current status of all the drugs in the Ocular Hypertension pipeline is provided in the ...
March 2018
61 pages
Cancer Cachexia: Drug Development Pipeline Study, H1 2018
US$ 806.00
... . The most comprehensive pipeline review “Cancer Cachexia- Drug Development Pipeline Study” provides in-depth analysis and update information on Cancer Cachexia pipeline drugs. Current status of all the drugs in the Cancer Cachexia pipeline is provided in the ...
March 2018
47 pages
Hypoparathyroidism: Drug Development Pipeline Study, H1 2018
US$ 806.00
... that impact the Hypoparathyroidism industry. Excerpts from- “Hypoparathyroidism- Drug Development Pipeline Study”: Hypoparathyroidism pipeline comprises of 6 drugs under development as of February 2018. Of these, 3 drugs are in Phase 1 and 1 drug is in phase 2. Further, 2 drugs remain in Pre ...
February 2018
32 pages
Impetigo: Drug Development Pipeline Study, H1 2018
US$ 806.00
... the Impetigo industry. Excerpts from- “Impetigo- Drug Development Pipeline Study”: Impetigo pipeline comprises of 4 drugs under development as of February 2018. Of these, 2 drugs are in Phase 2 and 1 drug is in phase 2/3. Further, 1 drug is in Pre-Clinical Stage. No drugs have ...
February 2018
22 pages
Pontine Glioma (DIPG):Drug Development Pipeline Study, H1 2018
US$ 806.00
... Diffuse Intrinsic Pontine Glioma (DIPG) industry. Excerpts from- “Diffuse Intrinsic Pontine Glioma (DIPG)- Drug Development Pipeline Study”: Pontine Glioma pipeline comprises of 24 drugs under development as of February 2018. Of these, 6 drugs are in Phase 1 and 3 drugs are in phase ...
February 2018
65 pages
